Exchange Announcement • 28 Sep 2026 15:00
Notice Regarding Discontinuation Of Development Of Gym329 (Emugrobart) For Obesity, Return Of License And Resumption Of Development For Sma
Exchange Announcement • 24 Jul 2026 15:00
Consolidated Financial Statements (Ifrs) (Non-Audited) (For The Six Months Ended June 30, 2026)
Exchange Announcement • 24 Jul 2026 15:00
Supplementary Materials Consolidated Financial Statements For The Six Months Ended June 30, 2026 (Ifrs)
Exchange Announcement • 23 Jul 2026 13:00
F. Hoffmann-La Roche Announces Half Year Results 2026
Exchange Announcement • 24 Apr 2026 16:00